NKS 01

Drug Profile

NKS 01

Alternative Names: 14alphaOHAT; NKS01

Latest Information Update: 22 Aug 2007

Price : $50

At a glance

  • Originator Snow Brand Milk Products
  • Developer Nippon Kayaku; Snow Brand Milk Products
  • Class Antineoplastics; Hormones; Small molecules
  • Mechanism of Action Aromatase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Discontinued Breast cancer

Most Recent Events

  • 11 Mar 2002 No development reported - Phase-II for Breast cancer in Japan (unspecified route)
  • 17 Oct 1994 Phase-II clinical trials for Breast cancer in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top